Safety, efficacy, and pharmacokinetics of single-tablet elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed, HIV-infected children: a single-arm, open-label trial.
Lancet Child Adolesc Health
; 1(1): 27-34, 2017 Sep.
Article
en En
| MEDLINE
| ID: mdl-30169223
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Lancet Child Adolesc Health
Año:
2017
Tipo del documento:
Article